10.1371/journal.pone.0137870.t001
Yanhong Yuan
Yanhong
Yuan
Xiajing Che
Xiajing
Che
Zhaohui Ni
Zhaohui
Ni
Yifei Zhong
Yifei
Zhong
Yinghui Qi
Yinghui
Qi
Xinghua Shao
Xinghua
Shao
Qin Wang
Qin
Wang
Liou Cao
Liou
Cao
Minfang Zhang
Minfang
Zhang
Yuanyuan Xie
Yuanyuan
Xie
Chaojun Qi
Chaojun
Qi
Lei Tian
Lei
Tian
Shan Mou
Shan
Mou
Demographics and Clinicopathologic Characteristics of Patients with IgAN.
Public Library of Science
2015
diastolic blood pressure
489 patients
validation cohort.ConclusionsThis study
Current Therapy Regimen
baseline diastolic blood pressure
Ren Ji Hospital
dbp
igan
multivariate Cox analysis
relapse
2015-09-15 03:13:46
Dataset
https://plos.figshare.com/articles/dataset/_Demographics_and_Clinicopathologic_Characteristics_of_Patients_with_IgAN_/1545150
<p>Values are presented as the means ± standard deviation (SD) if the variables showed a normal distribution and as medians (IQR) if the variables did not show a normal distribution; n (%) was used for the categorical variables.</p><p>SBP: systolic blood pressure; DBP: diastolic blood pressure; MAP: mean arterial blood pressure; SCr: serum creatinine; BUN: blood urea nitrogen; eGFR: estimated glomerular filtration rate; UA: serum uric acid; Hb: hemoglobin; ALB: serum albumin; UPE: 24-h urinary protein excretion; uRBC/HP: hematuria; TA-ALB: time-averaged serum albumin; TA-SCr: time-averaged serum creatinine; TA-eGFR: time-averaged eGFR; TA-UPE: time-averaged 24-h urinary protein excretion; Peak UPE: maximum level of UPE during follow-up; Peak SCr: maximum level of SCr during follow-up; Minimum ALB: minimum level of ALB; Minimum eGFR: minimum eGFR during follow-up; UPE ratio: (UPE at follow-up—baseline UPE) / baseline UPE.</p><p>Demographics and Clinicopathologic Characteristics of Patients with IgAN.</p>